Journal article
Feasibility of using a transition diabetes team to commence injectable therapies postdischarge from a tertiary hospital: A pilot, randomised controlled trial
F Pyrlis, R Ogrin, S Arthur, C Zhai, L Churilov, S Baqar, JD Zajac, EI Ekinci
BMJ Open | BMJ PUBLISHING GROUP | Published : 2019
Abstract
Objectives This study aimed to investigate if the use of a transition team was feasible for patients with diabetes being discharged from hospital on injectable diabetes therapies. Design Pilot, randomised controlled trial. Setting The trial was conducted between 2014 and 2016 conjointly by a tertiary referral hospital and a community healthcare provider. Participants Hospital inpatients (n=105) on new injectable diabetes therapies were randomised 1:1 to transition team or standard care. The transition team received in-home diabetes education 24-48 hours postdischarge, with endocrinologist review 2-4 weeks and 16 weeks postdischarge. Main outcome measures The primary outcome was feasibility, ..
View full abstractGrants
Funding Acknowledgements
The Lord Mayor's Charitable Foundation and the Estate of the Late Glen W A Griffiths funded this project. Elif I Ekinci was supported by the Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship, Viertel Clinical Investigatorship, Royal Australasian College of Physicians (RACP) Fellowship and Sir Edward Weary Dunlop Medical Research Foundation research grant.